Literature DB >> 21266512

Thyroid hormone and COUP-TF1 regulate kallikrein-binding protein (KBP) gene expression.

Yan-Yun Liu1, Teruyo Nakatani, Takahiko Kogai, Kaizeen Mody, Gregory A Brent.   

Abstract

Kallikrein-binding protein (KBP) is a component of the kallikrein-kinin system that mediates vasodilation and inhibits tumor growth by antagonizing vascular endothelial growth factor-mediated angiogenesis. We demonstrate that KBP gene expression is repressed by T(3) and modulated by the orphan nuclear receptor, chicken ovalbumin upstream promoter transcription factor 1 (COUP-TF1). In hypothyroid mice, KBP mRNA expression in the testis was increased 2.1-fold compared with euthyroid mice. We have identified two negative thyroid hormone response elements (nTREs) in the mouse KBP gene, nTRE1 located in the 5' flanking region (-53 to -29) and nTRE2, located in the first intron (104-132). We used functional assays, cofactor knockdown, and chromatin immunoprecipitation assays to characterize nTRE1 and nTRE2 in hepatic (HepG2) and testes (GC-1spg) cell lines. Reporter expression directed by both elements was enhanced with addition of thyroid hormone receptor and repressed with the addition of T(3). COUP-TF1 enhanced basal expression of both elements but blunted unliganded thyroid hormone receptor enhancement and T(3) repression of nTRE1 but not nTRE2. Both nTREs bound nuclear corepressor and binding increased in response to T(3). Nuclear corepressor knockdown resulted in loss of T(3) repression of both nTRE1 and nTRE2. COUP-TF1, which usually represses T(3) induction of positive thyroid hormone response elements, reverses T(3) repression mediated by nTRE1 in the mouse KBP gene. Endogenous KBP expression is repressed by T(3) and two functional nTREs, both of which are required, have been characterized in the KBP gene. COUP-TF1 may be an important factor to modulate expression of genes that are repressed by T(3).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21266512      PMCID: PMC3040047          DOI: 10.1210/en.2010-0580

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  63 in total

Review 1.  Thyroid hormone regulation of gene expression.

Authors:  G A Brent; D D Moore; P R Larsen
Journal:  Annu Rev Physiol       Date:  1991       Impact factor: 19.318

2.  A detailed functional and structural analysis of a major thyroid hormone inhibitory element in the human thyrotropin beta-subunit gene.

Authors:  D L Bodenner; M A Mroczynski; B D Weintraub; S Radovick; F E Wondisford
Journal:  J Biol Chem       Date:  1991-11-15       Impact factor: 5.157

3.  Roles of the P1, P2, and P3 residues in determining inhibitory specificity of kallistatin toward human tissue kallikrein.

Authors:  V C Chen; L Chao; J Chao
Journal:  J Biol Chem       Date:  2000-12-08       Impact factor: 5.157

4.  Antagonism between retinoic acid receptors and AP-1: implications for tumor promotion and inflammation.

Authors:  H F Yang-Yen; X K Zhang; G Graupner; M Tzukerman; B Sakamoto; M Karin; M Pfahl
Journal:  New Biol       Date:  1991-12

5.  Thyroid hormone inhibits thyrotropin gene expression via a position-independent negative L-triiodothyronine-responsive element.

Authors:  F E Carr; L L Kaseem; N C Wong
Journal:  J Biol Chem       Date:  1992-09-15       Impact factor: 5.157

6.  Effects of varying the position of thyroid hormone response elements within the rat growth hormone promoter: implications for positive and negative regulation by 3,5,3'-triiodothyronine.

Authors:  G A Brent; G R Williams; J W Harney; B M Forman; H H Samuels; D D Moore; P R Larsen
Journal:  Mol Endocrinol       Date:  1991-04

7.  Molecular cloning and sequence analysis of the mouse kallikrein-binding protein gene.

Authors:  K X Chai; J Chao; L Chao
Journal:  Biochim Biophys Acta       Date:  1991-12-02

8.  COUP orphan receptors are negative regulators of retinoic acid response pathways.

Authors:  P Tran; X K Zhang; G Salbert; T Hermann; J M Lehmann; M Pfahl
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

9.  Novel pathway for thyroid hormone receptor action through interaction with jun and fos oncogene activities.

Authors:  X K Zhang; K N Wills; M Husmann; T Hermann; M Pfahl
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

10.  Retinoid X receptor-COUP-TF interactions modulate retinoic acid signaling.

Authors:  S A Kliewer; K Umesono; R A Heyman; D J Mangelsdorf; J A Dyck; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

View more
  3 in total

1.  Nuclear corepressors mediate the repression of phospholipase A2 group IIa gene transcription by thyroid hormone.

Authors:  Pragya Sharma; Shalini Thakran; Xiong Deng; Marshall B Elam; Edwards A Park
Journal:  J Biol Chem       Date:  2013-04-29       Impact factor: 5.157

2.  Thyroid hormone receptor isoform-specific modification by small ubiquitin-like modifier (SUMO) modulates thyroid hormone-dependent gene regulation.

Authors:  Yan-Yun Liu; Takahiko Kogai; James J Schultz; Kaizeen Mody; Gregory A Brent
Journal:  J Biol Chem       Date:  2012-08-28       Impact factor: 5.157

3.  Kallistatin prevents ovarian hyperstimulation syndrome by regulating vascular leakage.

Authors:  Jianfang Huang; Yuling Mao; Quanxin Li; Honghai Hong; Ni Tang; Xiangjin Kang; Yuling Huang; Jianqiao Liu; Qing Gong; Yachao Yao; Lei Li
Journal:  J Cell Mol Med       Date:  2022-07-21       Impact factor: 5.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.